Randomized trial of infusion set function: steel versus teflon. - Wikidata - awgldk - TriplyDB

Randomized trial of infusion set function: steel versus teflon.

Randomized trial of infusion set function: steel versus teflon.

http://www.wikidata.org/entity/Q37460135

about

Fault detection and safety in closed-loop artificial pancreas systems Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs).Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.Clinical review: insulin pump-associated adverse events in adults and children.Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.Insulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 Subjects Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.Insulin Infusion Set Use: European Perspectives and Recommendations.An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release.Skin Oil Staining to Avoid Infusion Set Cannula Crimping: A Personal Observation.We Need More Research and Better Designs for Insulin Infusion Sets Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.Analysis of "Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life".Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.

P2860

Q26859052-1B90A8B7-24FA-4EBE-9270-8EFB3801428B Q30354179-E49614F8-5436-4D21-9E23-3342D0A21EF3 Q33454851-83209E9D-BB53-4742-A0A7-0900F64AFA0C Q35669227-D4F20141-F5EF-487A-A6B1-C2499EE52395 Q36340397-81E7F03B-B79A-421E-867D-77DED90863CB Q36340429-9233F606-5BAB-4B68-BAE6-D52144C4D825 Q36340536-9DF76723-813A-40C9-8466-AFEC62A0B27F Q36683272-1F72BE00-5251-4917-9159-A6F2DCE03CF8 Q37062173-E4262295-C667-4919-9295-AEEA833FF714 Q37292156-B898EF0C-7066-4AE5-A0B8-425D1FC2ECE0 Q38498029-CC97B270-7702-43F8-9556-E349ABACE71F Q38750029-9023810A-AAA1-44BA-952B-0F5A7430B46A Q38884258-DA7EDC30-D6E3-4914-963D-040973B988C2 Q41680762-CC593B53-D8FB-4DB8-AF2B-2384C8DE9968 Q42392244-DBB40577-8178-493C-8586-63652C6D6225 Q42724019-11D4425A-E955-40F1-98A6-30FB7AC8E6AB Q47553121-665E6112-28AE-4973-BDB6-21E6D0002B24 Q51169744-63C7DD64-767A-41DB-8D6F-A314886072A2 Q53518052-6C7333EC-17C5-4FE9-ACF3-FA092157817A Q53714062-77FBCF42-1262-4F84-AB06-CDA06C027FDB

P2860

Randomized trial of infusion set function: steel versus teflon.

http://www.wikidata.org/entity/Q37460135

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Randomized trial of infusion set function: steel versus teflon.

@en

Randomized trial of infusion set function: steel versus teflon.

@nl

type

label

Randomized trial of infusion set function: steel versus teflon.

@en

Randomized trial of infusion set function: steel versus teflon.

@nl

prefLabel

Randomized trial of infusion set function: steel versus teflon.

@en

Randomized trial of infusion set function: steel versus teflon.

@nl

P1433

Q37460135-9D27C074-0387-48EE-8D9B-68471921B77E

P1476

Q37460135-8702A840-4D08-46DA-98F7-1F11CB475C82

P2093

Q37460135-020480A6-CBC1-4996-90B7-C256E2CEE5D0

Q37460135-0D48DB97-E5E7-40A5-85BE-A256071ADCD6

Q37460135-5EC81789-6F65-4CC9-BB93-2B269546383F

Q37460135-8DCB4884-CAF4-466E-83E1-B0A822A04CD5

Q37460135-B681351F-00FF-43CF-9CB6-ED7F3E89CED7

Q37460135-F43592CC-AD6B-4E84-93E0-0F76257FCC1D

Q37460135-FDC95E04-FD51-4D0F-B527-CC22DB89B97D

P2860

Q37460135-12359E21-6EA4-4BF9-93D1-E7874D0C0AD4

Q37460135-30C3817C-6239-4750-8270-112E0F6E9EA1

Q37460135-55A11A01-2121-435D-8B9F-3648C4166C1F

Q37460135-6D2EA456-338F-4CC3-B4AC-C670FC9F1FFC

Q37460135-6E3B1DF0-F037-4E6F-AAA6-D9736647A50B

Q37460135-78AB4A0C-72CF-41FA-A34D-48FCF8E66684

Q37460135-8671B47E-7523-468F-ACBE-833FE4D893BD

Q37460135-879B4B43-4B6A-4C1E-825B-F899B34CD39A

Q37460135-A491E1EC-BD58-45A2-829A-F41CEC702CD3

Q37460135-AEB17196-0DE4-410A-A219-243CE266BEDD

P304

Q37460135-B039AC16-4E10-4ACE-9254-A9F5CFEE50D9

P31

Q37460135-D87D21DE-EF5C-4D9F-86C2-F022B93E86BC

P356

Q37460135-28DD84EC-D11F-4E72-835B-4D581ECCB719

P433

Q37460135-E641B09A-F822-4EFC-9702-F192FCFA22E9

P478

Q37460135-8C645999-E925-4624-A29B-DC7579A68CDE

P577

Q37460135-DAE6043D-2B38-4F15-B218-6017861B7C8C

P5875

Q37460135-1EA13BA1-2337-4A92-92B8-D992BF36DBFC

P698

Q37460135-CFD6A46A-A1CE-4254-9487-E127E9D034A4

P921

Q37460135-47F83AB5-F641-4F12-AB56-877C23590573

P932

Q37460135-213D24C0-7E25-4B56-B18B-CCF617D36612

P356

P1433

Diabetes technology & therapeutics

P1476

Randomized trial of infusion set function: steel versus teflon.

@en

P2093

Bruce A Buckingham

http://www.w3.org/2001/XMLSchema#string

Darrell M Wilson

http://www.w3.org/2001/XMLSchema#string

Gina Ferrari

http://www.w3.org/2001/XMLSchema#string

Kari Benasi

http://www.w3.org/2001/XMLSchema#string

Mark G Evans

http://www.w3.org/2001/XMLSchema#string

Parul J Patel

http://www.w3.org/2001/XMLSchema#string

Satya Shanmugham

http://www.w3.org/2001/XMLSchema#string

P2860

Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion

Metabolic decompensation in pump users due to lispro insulin precipitation

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.

Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.

Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.

Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.

Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents.

Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children.

Patient management of long-term continuous subcutaneous insulin infusion.

P304

15-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/DIA.2013.0119

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257348097

http://www.w3.org/2001/XMLSchema#string

P698

24090124

http://www.w3.org/2001/XMLSchema#string

P921

P932

3887416

http://www.w3.org/2001/XMLSchema#string